Literature DB >> 25356145

TNM and Modified Dukes staging along with the demographic characteristics of patients with colorectal carcinoma.

Ayşe Neslin Akkoca1, Serdar Yanık2, Zeynep Tuğba Ozdemir3, Fatma Gökşin Cihan4, Süleyman Sayar5, Tarık Gandi Cincin6, Akın Cam7, Cahit Ozer8.   

Abstract

AIM: Colon adenocarcinoma, is the most common cancer in gastrointesinal system (GIS). The whole world is an important cause of morbidity and mortality. TNM and modified Dukes classification which has great importance in the diagnosis and treatment of Colorectal cancer (CRC). TNM and Modified Dukes classification results of histopathological examination and the demographic characteristics of patients and their relation were investigated.
MATERIALS AND METHODS: Lower gastrointestinal operation results of 85 patients were examined accepted to clinical Pathology between January 1997-November 2013. Colon cancer had been diagnosed at 85 patients with pathology materials and staging was done according to the TNM and Modified Duke classification. The demographic characteristics of patients, differentiation grade, lymph node involvement, serous involvement were evaluated retrospectively.
RESULTS: In this study 37 patients (43.52%) were men and 48 (56.47%) were women. Ages of patients were between 19 and 87 with a mean age of 57.31 ± 15.31. Lymph node, differentiation, serosa involvement, Modified Dukes and TNM classification was assessed according to sex and age. TNM classification by sex was not statistically significant (p > 0.05). There was no statistically significant relationship between age and differentiation (p = 0.085). Value of differentiation increased towards from 1 to 3 inversely proportional to age. So young patients defined as well-differentiated at the conclusion. Negative relationship was evaluated between age and TNM Class variables. As a result, the relationship between age and TNM was not significant (p > 0.05). However, with increasing age the degree of staging was also found to increase. TNM classification was associated with the differentiation and it was significant (p = 0.043).
CONCLUSION: Colon cancer, when contracted at an early stage, it is suitable for surgery and curative treatment can be done with minimal morbidity and mortality. However, some of the patients have advanced disease at diagnosis and their 5-year survival rate is only 8%. Every year there is prolongation of overall survival of colon cancer. It is so common cancer type so that determination of prognostic factors, disease staging and treatment strategy which affects survival is significant.

Entities:  

Keywords:  Gastrointesinal system (GIS); Modified Dukes staging; TNM; colorectal cancer (CRC)

Year:  2014        PMID: 25356145      PMCID: PMC4211795     

Source DB:  PubMed          Journal:  Int J Clin Exp Med        ISSN: 1940-5901


  37 in total

1.  Increasing negative lymph node count is independently associated with improved long-term survival in stage IIIB and IIIC colon cancer.

Authors:  Paul M Johnson; Geoff A Porter; Rocco Ricciardi; Nancy N Baxter
Journal:  J Clin Oncol       Date:  2006-08-01       Impact factor: 44.544

Review 2.  Lymph node evaluation and survival after curative resection of colon cancer: systematic review.

Authors:  George J Chang; Miguel A Rodriguez-Bigas; John M Skibber; Virginia A Moyer
Journal:  J Natl Cancer Inst       Date:  2007-03-21       Impact factor: 13.506

3.  The nucleotide sequence of a rat 18 S ribosomal ribonucleic acid gene and a proposal for the secondary structure of 18 S ribosomal ribonucleic acid.

Authors:  Y L Chan; R Gutell; H F Noller; I G Wool
Journal:  J Biol Chem       Date:  1984-01-10       Impact factor: 5.157

4.  Menstrual cycle-dependent variations of breast cyst fluid proteins and sex steroid receptors in the normal human breast.

Authors:  J S Silva; G S Georgiade; W G Dilley; K S McCarty; S A Wells; K S McCarty
Journal:  Cancer       Date:  1983-04-01       Impact factor: 6.860

5.  Population-attributable risk for colon cancer in Italy.

Authors:  C La Vecchia; C Braga; S Franceschi; L Dal Maso; E Negri
Journal:  Nutr Cancer       Date:  1999       Impact factor: 2.900

6.  Trends in screening for colorectal cancer--United States, 1997 and 1999.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2001-03-09       Impact factor: 17.586

7.  Curative resection of colorectal adenocarcinoma: multivariate analysis of 5-year follow-up.

Authors:  C Han-Shiang
Journal:  World J Surg       Date:  1999-12       Impact factor: 3.352

8.  Characterization of estrogen receptor messenger RNA in human breast cancer.

Authors:  P J Barrett-Lee; M T Travers; R A McClelland; Y Luqmani; R C Coombes
Journal:  Cancer Res       Date:  1987-12-15       Impact factor: 12.701

Review 9.  Colorectal carcinoma: diagnostic, prognostic, and molecular features.

Authors:  Carolyn C Compton
Journal:  Mod Pathol       Date:  2003-04       Impact factor: 7.842

10.  Young age is not a poor prognostic marker in colorectal cancer.

Authors:  Y F Chung; K W Eu; D Machin; J M Ho; D C Nyam; A F Leong; Y H Ho; F Seow-Choen
Journal:  Br J Surg       Date:  1998-09       Impact factor: 6.939

View more
  19 in total

1.  Role of microRNA-141 in colorectal cancer with lymph node metastasis.

Authors:  Li Feng; Hongqing Ma; Liang Chang; Xinliang Zhou; Na Wang; Lianmei Zhao; Jing Zuo; Yudong Wang; Jing Han; Guiying Wang
Journal:  Exp Ther Med       Date:  2016-09-27       Impact factor: 2.447

2.  Laparoscopic colectomy for transverse colon cancer: comparative analysis of short- and long-term outcomes.

Authors:  Weizheng Sheng; Bo Zhang; Weifeng Chen; Dayong Gu; Weidong Gao
Journal:  Int J Clin Exp Med       Date:  2015-09-15

3.  Overexpression of Wnt7α protein predicts poor survival in patients with colorectal carcinoma.

Authors:  Yichong Wang; Jiufeng Wei; Shujun Zhang; Guodong Li; Tao Zhang; Xin Yu; Hongsheng Chen; Ming Liu
Journal:  Tumour Biol       Date:  2015-06-09

4.  Extricating the Association Between the Prognostic Factors of Colorectal Cancer.

Authors:  Balamuralikrishnan Balasubramanian; Arun Meyyazhagan; Younis Mohd; Haripriya Kuchi Bhotla; Suresh Kumar Shanmugam; Mithun Kumar Ramesh Kumar; Manikantan Pappusamy; Karthick Kumar Alagamuthu; Sasikala Keshavarao; Vijaya Anand Arumugam
Journal:  J Gastrointest Cancer       Date:  2020-10-13

5.  Macroscopic serosal classification of colorectal cancer and its clinical significance.

Authors:  Yong-Peng Wang; Peng-Tao Guo; Zhi Zhu; Hao Zhang; Yan Xu; Si-Ping Ma; Zhen-Ning Wang; Hui-Mian Xu
Journal:  Int J Clin Exp Med       Date:  2015-11-15

6.  Video-assisted thoracoscopic surgery versus open resection of lung metastases from colorectal cancer.

Authors:  Zhiliang Hou; Haoliang Zhang; Linyan Gui; Wenbo Wang; Song Zhao
Journal:  Int J Clin Exp Med       Date:  2015-08-15

7.  MicroRNA-4463 facilitates the development of colon cancer by suppression of the expression of PPP1R12B.

Authors:  J Tan; T Lu; J Xu; Y Hou; Z Chen; K Zhou; Y Ding; B Jiang; Y Zhu
Journal:  Clin Transl Oncol       Date:  2022-01-22       Impact factor: 3.405

8.  Novel STAT binding elements mediate IL-6 regulation of MMP-1 and MMP-3.

Authors:  Samuel J Cutler; James D Doecke; Ibtisam Ghazawi; Jinbo Yang; Lyn R Griffiths; Kevin J Spring; Stephen J Ralph; Albert S Mellick
Journal:  Sci Rep       Date:  2017-08-17       Impact factor: 4.379

9.  Squamous cell carcinoma of the ascending colon: two cases.

Authors:  Abdelhai Abdelqader; Ramez Jabaji; Mohammed Albugeaey; Caren Palese
Journal:  J Community Hosp Intern Med Perspect       Date:  2017-03-31

10.  A panel of microRNA signature in serum for colorectal cancer diagnosis.

Authors:  Mingxia Zhu; Zebo Huang; Danxia Zhu; Xin Zhou; Xia Shan; Lian-Wen Qi; Lirong Wu; Wenfang Cheng; Jun Zhu; Lan Zhang; Huo Zhang; Yan Chen; Wei Zhu; Tongshan Wang; Ping Liu
Journal:  Oncotarget       Date:  2017-03-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.